F. Wolff

Oncogenic GLI1 and STAT1/3 activation drives immunosuppressive tryptophan/kynurenine metabolism via synergistic induction of IDO1 in skin cancer cells

A. Risch, R. Reischl, C. Huber, 2020, bioRxiv.

Protective effects of RU 41740, a bacterial immunomodulator, against experimental infections: induction of cytokine and immunoglobulin release in mice after oral administration.

D. Guy‐grand, C. Bloy, P. Allouch, 1999, International journal of immunopharmacology.

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation

L. Pleyer, R. Greil, A. Risch, 2017, Cell Communication and Signaling.

Hedgehog/GLI Signaling Activates Suppressor of Cytokine Signaling 1 (SOCS1) in Epidermal and Neural Tumor Cells

A. Frischauf, T. Eichberger, C. Hauser-kronberger, 2013, PloS one.

Synergistic cross‐talk of hedgehog and interleukin‐6 signaling drives growth of basal cell carcinoma

P. Lackner, H. Lehrach, M. Kasper, 2018, International journal of cancer.

Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation

A. Frischauf, H. Esterbauer, W. Gruber, 2013, Oncogene.

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation

L. Pleyer, R. Greil, A. Risch, 2017, Cell Communication and Signaling.